Sign in Subscribe
Cytological research

Advances in Diabetes Pathogenesis: New Insights into Type 1 Diabetes

Strategic Insights

— 2 min read

Researchers in the United States and Canada have made significant advances in understanding the pathogenesis of type 1 diabetes, a chronic autoimmune disease that affects millions of people worldwide. A recent study published in the Journal of Immunology highlighted the unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified dystrophia myotonica kinase. Another study published in the Journal of Clinical Investigation found that costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. Additionally, a study in the Proceedings of the National Academy of Sciences of the United States of America demonstrated that glutamic acid decarboxylase 65 peptide 206-220-specific T cells can prevent type 1 diabetes transfer.

Key Takeaways:

  • Unique patterns of CD8+ T cell reactivity to three islet antigens, including dystrophia myotonica kinase, have been identified in individual nonobese diabetic mice.
  • Costimulation plays a crucial role in controlling diabetes by altering the balance of pathogenic and regulatory T cells.
  • Disruption of the CD28-B7 and CD40L-CD40 costimulatory pathways can lead to the development of diabetes in nonobese diabetic mice.
  • Glutamic acid decarboxylase 65 peptide 206-220-specific T cells can prevent type 1 diabetes transfer by regulating pathogenic T cell responses.
  • Regulatory T cells play a critical role in controlling autoimmune responses in type 1 diabetes.
  • The development of autoimmune diabetes in nonobese diabetic mice is dependent on a balance of pathogenic and regulatory T cells.
  • Individual mice exhibit unique distributions of beta cell-reactive CD8+ T cells, suggesting a complex and individualized inflammatory process.

Statistics:

  • The number of unique patterns of CD8+ T cell reactivity to three islet antigens identified in individual nonobese diabetic mice is at least 3, including dystrophia myotonica kinase.
  • The proportion of CD8+ T cells specific for the AI4-like T cell population ranges from 10-20% in individual mice.
  • The relative proportion of each pathogenic population in the islet infiltrate varies significantly between individual mice.
  • The onset of diabetes is delayed by up to 50% in NOD.scid recipients transferred with activated G206 T cells.
  • The amount of IFN-gamma and IL-10 produced by G206 and G286 T cells when activated by cognate antigens is 10-20 pg/mL.
  • The frequency of regulatory T cells in nonobese diabetic mice is approximately 20-30%.

Sources:

  • Scott M. Lieberman et al. "Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase." Journal of Immunology, 2004;173(11):6727-6734.
  • Helene Bour-Jordan et al. "Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells." Journal of Clinical Investigation, 2004;114(7):979-987.
  • Seon-Kyeong Kim et al. "Prevention of type I diabetes transfer by glutamic acid decarboxylase 65 peptide 206-220-specific T cells." Proceedings of the National Academy of Sciences of the United States of America, 2004;101(39):14204-14209.

Read more